Chief Executive Officer, OBI Pharma, Inc. Vice President and Global Head of Regulatory Science for Oncology, Bristol-Myers Squibb (BMS) Company - Postdoctoral Training, Cold Spring Harbor Laboratory New York PhD, University of Notre Dame
Chairman, Nan Shan Life Insurance Co. Ltd. Chairman, Nan Shan Life Charity Foundation Board Member, Nan Shan General Insurance Co. Ltd. Board Member, Ruentex Development Co. Ltd. Board Member, Ruentex Industries Co. Ltd. Board Member, Ruentex Material Co. Ltd. Board Member, Ruentex Enginering & Construction Co. Ltd. Board Member, Gogoro Inc. Board Member, Tang Prize Foundation Board Member, The Yin Shu-Tien Memorial Hospital - PhD, University of Oxford
Venture Partner Founder, Vivo Capital LLC Executive Director, Taiwan Bio Industry Organization Independent Board Member, Lumosa Therapeutics Co., Ltd. Board Member, Formosa Pharmaceuticals, Inc. Consultant, National Health Research Institutes, Taiwan Consultant, Lifemax Biotechnology, Inc. Consultant, Merry Life Biomedical Co., Ltd.
Advisory Committee Member on Infectious Disease Prevention and Control, Ministry of Health and Welfare President, Intelligent-Bio Co., Ltd. Vice Chairman, Asia Pacific Biosafety Association (A-PBA) Pharmacist - PhD, University of Rhode Island
CFO & VP of Corporate Development, ScinoPharm Taiwan CFO, Foresee Pharma VP & CFO, Diamond Biofund CPA qualifications in Taiwan, U.S.A. and China - MBA, University of California, Berkeley Master in Accounting, University of Southern California
Finance Manager of Investment Management Department, Ruentex Group Supervisor of several companies - EMBA in International Finance, National Taipei University Master of Biotech, University of Queensland BS in genetics, University of Queensland in Australia
Chief Operating Officer, OBI Pharma, Inc. Certified Public Accountant, Taiwan Certified Public Accountant, United Kingdom International Certified Internal Auditor - Master of Accounting, National Chengchi University